Filter Results:
(2,525)
Show Results For
- All HBS Web
(5,300)
- People (16)
- News (1,939)
- Research (2,525)
- Events (3)
- Multimedia (214)
- Faculty Publications (1,884)
Show Results For
- All HBS Web
(5,300)
- People (16)
- News (1,939)
- Research (2,525)
- Events (3)
- Multimedia (214)
- Faculty Publications (1,884)
Sort by
- April 2012 (Revised February 2013)
- Case
Learning About Reducing Hospital Mortality at Kaiser Permanente
By: Anita Tucker
In 2011, Kaiser Permanente Northern California (KPNC) region's efforts to reduce mortality in their 21 hospitals is showing promise. They developed and launched a region-wide initiative to improve the treatment of sepsis, a serious and often deadly medical condition.... View Details
Keywords: Change Management; Health Care and Treatment; Performance Improvement; Health Industry; California
Tucker, Anita. "Learning About Reducing Hospital Mortality at Kaiser Permanente ." Harvard Business School Case 612-093, April 2012. (Revised February 2013.)
- June 1999 (Revised May 2000)
- Exercise
Working with your "Shadow Partner" in the healthcare industry (A)
By: Richard L. Nolan
Intended to introduce individuals to search engines and databases on the Internet, in particular those that are available to HBS. This exercise is a more difficult version of Working with Your "Shadow Partner" and is intended for those with some previous Internet... View Details
Nolan, Richard L. Working with your "Shadow Partner" in the healthcare industry (A). Harvard Business School Exercise 399-177, June 1999. (Revised May 2000.)
- October 2006 (Revised August 2007)
- Case
Calloway Laboratory: Pee for Profit
By: Richard G. Hamermesh and David Kiron
Describes the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. View Details
Keywords: For-Profit Firms; Health Care and Treatment; Health Testing and Trials; Growth and Development Strategy; Market Entry and Exit; Health Industry
Hamermesh, Richard G., and David Kiron. "Calloway Laboratory: Pee for Profit." Harvard Business School Case 807-040, October 2006. (Revised August 2007.)
- November 2016
- Case
Pete & Gerry's
By: Jose Alvarez and Natalie Kindred
Keywords: "Pete & Gerry's; " Eggs; Egg Industry; Avian Flu; Cage Free; Free Range; Agribusiness; Agriculture; Industry Structure; Industry Evolution; Price Volatility; Small Business; Strategy Formulation; Branding; Marketing; Premium Brand; Growth; Consumer; Consumer Behavior; Animal Welfare; Retail; Grocery; Food Labeling; Animal-Based Agribusiness; Advertising Campaigns; Business Model; Change; Change Management; Disruption; Transition; Trends; Volatility; Customer Value and Value Chain; Entrepreneurship; Food; Ethics; Health; Problems and Challenges; Operations; Sales; Risk and Uncertainty; Quality; Public Opinion; Value; Strategy; Agriculture and Agribusiness Industry; Retail Industry; United States
Alvarez, Jose, and Natalie Kindred. "Pete & Gerry's." Harvard Business School Case 517-048, November 2016.
- 11 Jun 2014
- Research & Ideas
In the Future of Sports Investing, Media Is the Best Bet
redefined," Higgins says. "The younger generation doesn't care as much about cable TV." And for older sports fans, mobile devices are gaining popularity because they allow for multitasking. "Wyc Grousbeck was on a tour... View Details
- February 2010
- Article
Input Constraints and the Efficiency of Entry: Lessons from Cardiac Surgery
By: David M. Cutler, Robert S. Huckman and Jonathan T. Kolstad
Prior studies suggest that, with elastically supplied inputs, free entry may lead to an inefficiently high number of firms in equilibrium. Under input scarcity, however, the welfare loss from free entry is reduced. Further, free entry may increase use of high-quality... View Details
Keywords: Government Legislation; Health Care and Treatment; Medical Specialties; Market Entry and Exit; Welfare; Health Industry; Pennsylvania
Cutler, David M., Robert S. Huckman, and Jonathan T. Kolstad. "Input Constraints and the Efficiency of Entry: Lessons from Cardiac Surgery." American Economic Journal: Economic Policy 2, no. 1 (February 2010): 51–76.
- July 2014 (Revised January 2017)
- Course Overview Note
Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Spring 2016 class Building Life Science Businesses.7 View Details
Keywords: Healthcare Ventures; Entrepreneurial Management; Entrepreneurship; Entrepreneurs; Health Care and Treatment; Health Testing and Trials; Medical Specialties; Health Industry; Health Industry; Health Industry; Asia; North America; Europe
Hamermesh, Richard G. "Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus." Harvard Business School Course Overview Note 815-003, July 2014. (Revised January 2017.)
- January 1983 (Revised February 1988)
- Case
Hospital Corp. of America (A)
By: W. Carl Kester
HCAs ratio of debt to total capital is approaching 70%, jeopardizing its single-A bond rating. Students must determine an appropriate target debt ratio for HCA in light of its growth objectives, its acquisition strategy and its changing regulatory environment. View Details
Keywords: Situation or Environment; Capital Structure; Health Care and Treatment; Borrowing and Debt; Health Industry; Tennessee
Kester, W. Carl. "Hospital Corp. of America (A)." Harvard Business School Case 283-053, January 1983. (Revised February 1988.)
- January 2021 (Revised June 2021)
- Case
Hester Pharmaceuticals (A): A Pricing Dilemma
By: Dante Roscini and John Masko
In August 2019, the leadership of Hester Pharmaceuticals (Hester) had a problem. Italy promised to be a key market for their new breakthrough oncology drug Akrozumab, but for almost two years, its single-payer healthcare system had been unable to agree with Hester on a... View Details
Keywords: Macroeconomics; Trade; Price; Global Range; Global Strategy; Globalized Markets and Industries; Health Care and Treatment; Patents; Monopoly; Negotiation; Business and Government Relations; Risk and Uncertainty; Human Needs; Business Strategy; Commercialization; Pharmaceutical Industry; Italy
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (A): A Pricing Dilemma." Harvard Business School Case 721-001, January 2021. (Revised June 2021.)
- 09 Dec 2014
- First Look
First Look: December 9
The survey showed, for instance, that 1) the highly educated, ambitious women and men of HBS don't differ much in terms of what they value and hope for in their lives and careers; 2) it simply isn't true that a large proportion of HBS alumnae have "opted out"... View Details
Keywords: Sean Silverthorne
- 17 Feb 2016
- Research & Ideas
Man vs. Machine: Which Makes Better Hires?
who has studied how companies make organizational decisions in industries such as health care and education. “They are figuring out how to use the information of managers and combine it with this new... View Details
- June 2010 (Revised December 2019)
- Case
Piramal e-Swasthya (A): Attempting Big Changes for Small Places - in India and Beyond
By: Rosabeth M. Kanter and Matthew Bird
Anand Piramal and his team sought to "democratize healthcare" in India through the development of a new service delivery model. If Henry Ford could build and deliver cars to everyone in the United States, Piramal thought, then why can't India deliver healthcare to the... View Details
Keywords: Health Care and Treatment; Service Delivery; Social Entrepreneurship; Change Management; Emerging Markets; Health Industry; India
Kanter, Rosabeth M., and Matthew Bird. "Piramal e-Swasthya (A): Attempting Big Changes for Small Places - in India and Beyond." Harvard Business School Case 310-134, June 2010. (Revised December 2019.)
- February 2020
- Teaching Note
Ariadne Labs: Building Impactful Partnerships
By: Ariel D. Stern and Sarah Mehta
Teaching Note for HBS No. 619-017. View Details
- March 2017 (Revised March 2017)
- Case
OpenNotes
By: Jeffrey Rayport and Annelena Lobb
In 2017, executives at OpenNotes, a national movement to improve the relationship between doctors and patients by sharing doctors’ visit notes about patients with patients, were considering options in efforts to achieve scale. The movement hoped to reach 50 million... View Details
Keywords: Health Care and Treatment; Technology Adoption; Growth and Development Strategy; Health Industry; Health Industry; United States
Rayport, Jeffrey, and Annelena Lobb. "OpenNotes." Harvard Business School Case 817-080, March 2017. (Revised March 2017.)
- 20 Sep 2011
- First Look
First Look: September 20
Hospital: Cardiac Care for the Poor (B) Tarun Khanna and Tanya BijlaniHarvard Business School Supplement 712-402 Narayana Hrudayalaya (NH) has expanded into a multi-specialty health city in Bangalore and has... View Details
Keywords: Sean Silverthorne
- Research Summary
Overview
Chu's research is focused on business and low income sectors, particularly in the use of commercial platforms to deliver what has traditionally been considered public responsibilities. In the last three decades, business models have emerged to meet the underserved... View Details
Keywords: Impact Investing; Microfinance; Base Of The Pyramid; Role Of Profit And Social Impact; Private Sector Development; Emerging Markets; Business Ventures; Health Care and Treatment; Management; Social Enterprise; Strategy; Health Industry; Health Industry; Health Industry; Latin America; North and Central America; Asia; Africa
- April 1991 (Revised April 1992)
- Case
Hospital Sector in 1992
Examines the major issues facing the hospital sector in 1992. The environment surrounding the industry is one of great uncertainty and rapid change, and involves significant public policy questions. Describes recent trends, issues and new types of competitors that... View Details
Keywords: Risk and Uncertainty; Nonprofit Organizations; Competition; Health Care and Treatment; Policy; Change; Health Industry; United States
Teisberg, Elizabeth O. "Hospital Sector in 1992." Harvard Business School Case 391-167, April 1991. (Revised April 1992.)
- 15 Apr 2002
- Research & Ideas
In the Virtual Dressing Room Returns Are A Real Problem
comparisons based on independent performance evaluations. (Although for online purchases, as for catalog purchases, brand names help consumers infer certain aspects of quality or fit, especially for consumers making repeat purchases.)... View Details
- December 2006 (Revised August 2008)
- Case
Pervasis Therapeutics, Inc.
By: Robert F. Higgins and Virginia Fuller
In May 2005, Steve Bollinger was about to become president and chief operating officer of Pervasis Therapeutics, a small cell therapy start-up in Cambridge, Mass. If proven successful, Pervasis' product, Vascugel, could change the way vascular disease is treated and... View Details
Keywords: Business Startups; Venture Capital; Financial Strategy; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Health Testing and Trials; Health Industry; Cambridge
Higgins, Robert F., and Virginia Fuller. "Pervasis Therapeutics, Inc." Harvard Business School Case 807-026, December 2006. (Revised August 2008.)
- March 2015 (Revised February 2022)
- Supplement
CV Ingenuity (B): Epilogue
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen used a lea-nfunding, iconoclastic strategy for his start up for a drug eluding balloon for peripheral artery disease. His giant competitors were first movers. Did Duke obtain the funding he sought? How did his DEB fare versus that of his competitors?
The... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Strategy; Health Industry; Health Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (B): Epilogue." Harvard Business School Supplement 315-087, March 2015. (Revised February 2022.)